Localized cutaneous leishmaniasis due to leishmania infantum in a patient treated with infliximab

Dermatology

Volumn 220, Issue 1, 2010, Pages 63-65

  Hakimi, S ^a   Riviere S ^a   Del Giudice, P ^b   Dereure, J ^a   Le Quellec, A ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b Centre Hospitalier Bonnet   (France)

Author keywords

Cutaneous leishmaniasis, infliximab; Leishmania infantum; Leishmaniasis; Tumor necrosis factor a antagonists

Indexed keywords

INFLIXIMAB; MEGLUMINE ANTIMONATE;

ADULT; ALGERIA; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LEISHMANIA INFANTUM; MALE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SKIN NODULE; STAINING; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIPROTOZOAL AGENTS; ANTIRHEUMATIC AGENTS; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76649113077     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258675     Document Type: Article

References (25)

1. Del Giudice P, Marty P, Lacour JP: Leishmaniose cutanée autochtone en France métropolitaine. Ann Dermatol Venereol 2001; 128: 1057-1062.
2. Del Giudice P, Marty P, Lacour JP, Perrin C, Pratlong F, Haas H, Dellamonica P, Le Fichoux Y: Cutaneous leishmaniasis due to Leishmania infantum . Arch Dermatol 1998; 134: 193-198.
3. Marty P, Izri A, Ozon C, Haas P, Rosenthal E, Del Giudice P, Godenir J, Coulibaly E, Gari-Toussaint M, Delaunay P, Ferrua B, Haas H, Pratlong F, Le Fichoux Y: A century of leishmaniasis in Alpes-Maritimes, France. Ann Trop Med Parasitol 2007; 101: 1-12.
4. Pratlong F, Rioux JA, Marty P, Faraut F, Dereure J, Lamotte G, Dedet JP, Gambarelli F: Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features. J Clin Microbiol 2004; 42: 4077-4082.
5. Basset D, Faraut F, Marty P, Dereure J, Rosenthal E, Mary C, Pratlong F, Lachaud L, Bastien P, Dedet JP: Visceral leishmaniasis in organ transplant recipients: 11 new cases and review of the literature. Microb Infect 2005; 7: 1370-1375.
6. Alvar J, Canavate C, Guttierez-Solar B, et al: Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10: 298-319.
7. Del Giudice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty P, Gastaut JA, Costagliola D, Rosenthal E, the Clinical Epidemiologic Group of the French Hospital Database on HIV: Impact of highly active antiretroviral therapy on the Incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis 2002; 186: 1366-1370.
8. Fernandez-Guerrero ML, Robles P, Rivas P, Mojer F, Muniz G, De Gorgolas M: Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop 2004; 90: 11-16.
9. Castellino G, Govoni M, Lo Monaco A, Montecucco C, Colombo F, Trotta F: Visceral leishmaniasis complicating a connective tissue disease: three case reports from Italy. Lupus 2004; 13: 201-203.
10. Hachicha I, Sellani M, Fourati H, Hidji N, Baklouti S: Cutaneous leishmaniasis in rheumatoid arthritis. Rev Med Interne 2009; 30: 609-612.
11. Couppié P, Clyti E, Sobesky M, Bissuel F, Del Giudice P, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R: Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana. Br J Dermatol 2004; 151: 1165-1171.
12. Tuon FF, Sabbaga Amato V, Floeter-Winter LM, De Andrade Zampieri R, Amato Neto V, Siqueira Franca FO, Shikanai-Yasuda MA: Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids: first report. Int J Dermatol 2007; 46: 628-630.
13. Pittalis S, Nicastri E, Spinazzola F, Ghirga P, De Marco M, Paglia MG, Narciso P: Leishmania infantum leishmaniasis in corticosteroid- treated patients. BMC Infect Dis 2006; 18: 177.
14. Gontijo CM, Pacheco RS, Orefice F, Lasmar E, Silva ES, Melo MN: Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient. Mem Inst Oswaldo Cruz 2002; 97: 751-753.
15. Titus RG, Sherry B, Cerami A: Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 1989; 170: 2097-2104.
16. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW: Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 2000; 68: 6289-6293.
17. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21:S423-S435.
18. Bagalas V, Kioumis I, Argyropoulou P, Patakas D: Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept. Clin Rheumatol 2007; 26: 1344-1345.
19. Bassetti M, Pizzorni C, Gradoni L, Del Bono V, Cutolo M, Viscoli C: Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology 2006; 45: 1446-1448.
20. Teknokidou MG, Skopouli FN: Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection? Clin Rheumatol 2008; 27: 541-542.
21. Fabre S, Gibert C, Lechiche C, Dereure J, Jorgensen C, Sany J: Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Clin Exp Rheumatol 2005; 23: 891-892.
22. Ludwig C, Guyon G, Jorgensen C, Rodière M: Présentation à la Société Française de Pédiatrie. 2005. http://www.sfpediatrie.com/ uploads/media/complications-infectieuses- des-antiTNF-alpha antagonists-C. Ludwig.pdf.
23. Romani-Costa V, Sanchez C, Moya F, Estany C: Visceral leishmaniasis related to infliximab administration. Enferm Infecc Microbiol Clin 2004; 22: 310.
24. Baixoli Rubio A, Rodriguez Gorriz E, Campos Fernandez C, Calvo Catala J, Garcia Vicente S: Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis. An Med Interna 2003; 20: 276-277.
25. Balato A, Balato N, Patruno C, Gallo L, Ayala F: Visceral leishmaniasis infection in a patient with psoriasis treated with efalizumab. Dermatology 2008; 217: 360-361.